Recent Finacing
Recent Raise
Cell-Easy is a French CDMO manufacturing ready-to-inject adipose-derived allogeneic stem cells under cGMP (ANSM-inspected) for preclinical and Phase 1–3 clinical trials, supplying biotech, pharma, and research centers.
Focus Areas
Recent Investors
Funding round
Investors
See the team members at Cell-Easy.
